Titan Pharmaceuticals Inc
TTNPDelisted Oct 2, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000910267
Titan Pharmaceuticals Inc was delisted on Oct 2, 2025; its insiders filed their last Form 4 on Oct 8, 2025; 18 institutions reported holding it in 13F filings for Q3 2025, worth $107.1K in total; no superinvestor held it.
Holders of 5% or more of TTNP
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Titan Pharmaceuticals Inc, largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of Titan Pharmaceuticals Inc on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
Schedule 13D and 13G filings on Titan Pharmaceuticals Inc, newest first.
No Schedule 13D or 13G filings on Titan Pharmaceuticals Inc are on file.
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Titan Pharmaceuticals Inc shares.
No Form 144 notices for Titan Pharmaceuticals Inc are on file.